Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.

被引：0
|
作者：
Zdenkowski, Nicholas
D'Silva, Shefi Mary
Lawson, Kenny
Reeves, Penny
Boyle, Frances M.
机构：
[1] Univ Newcastle, Callaghan, NSW, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12637
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy for operable breast cancer
    Mieog, J. S. D.
    van der Hage, J. A.
    de Velde, C. J. H. van
    [J]. BRITISH JOURNAL OF SURGERY, 2007, 94 (10) : 1189 - 1200
  • [2] Neoadjuvant chemotherapy in operable breast cancer
    Giardina, G
    Chini, C
    Fagnoni, E
    Pigni, A
    Membrini, F
    Masera, LR
    Proserpio, I
    Martinelli, B
    Pinotti, G
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 44 - 44
  • [3] Factors associated with delays in receipt of neoadjuvant chemotherapy in patients with operable breast cancer.
    Wooster, Margaux
    DeStephano, David
    Beauchemin, Melissa
    Wang, Shikun
    Hur, Chin
    Wright, Jason Dennis
    Hershman, Dawn L.
    Accordino, Melissa Kate
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Neoadjuvant chemotherapy in operable breast cancer: The pros
    Mamounas, Eleftheriors R.
    [J]. BREAST CARE, 2006, 1 (06) : 348 - 351
  • [5] Neoadjuvant chemotherapy for primary operable breast cancer
    Halberg, Anne Krag
    Gravesen, Charlotte Dahl
    Cold, Soren
    Jensen, Jeanette Dupont
    [J]. DANISH MEDICAL JOURNAL, 2020, 67 (12):
  • [6] NEOADJUVANT CHEMOTHERAPY IN OPERABLE BREAST-CANCER
    SCHOLL, SM
    ASSELAIN, B
    PALANGIE, T
    DORVAL, T
    JOUVE, M
    GIRALT, EG
    VILCOQ, J
    DURAND, JC
    POUILLART, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1668 - 1671
  • [7] Evaluation of topoisomerase II-alpha as a predictor of clinical and pathological response to neoadjuvant chemotherapy in operable breast cancer.
    Burcombe, RJ
    Makris, A
    Richman, PI
    Nayagam, M
    Daley, F
    Turley, H
    Wilson, GD
    Harris, AL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S64 - S64
  • [8] Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer
    Read, Rebecca L.
    Flitcroft, Kathy
    Snook, Kylie L.
    Boyle, Frances M.
    Spillane, Andrew J.
    [J]. ANZ JOURNAL OF SURGERY, 2015, 85 (05) : 315 - 320
  • [9] Neoadjuvant chemotherapy in the treatment of operable breast cancer. Preliminary results of a phase II pilot study
    Bellantone, R
    Lombardi, CP
    Cefaro, GA
    Rossi, S
    Nardone, L
    Minelli, S
    Raffaelli, M
    De Crea, C
    Crucitti, F
    [J]. 10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 743 - 746
  • [10] Does neoadjuvant chemotherapy in operable breast cancer increase breast conservation?
    Abd El-Bary, N. M.
    El-Kased, A. F.
    Aiad, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345